Global mitotic phosphorylation of C2H2 zinc finger protein linker peptides

Cell Cycle

Volumn 10, Issue 19, 2011, Pages 3327-3336

  Rizkallah, Raed ^a   Alexander, Karen E ^a   Hurt, Myra M ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Biomarker; Mitosis; Phosphorylation; Transcription factor; YY1; Zinc finger

Indexed keywords

ALPHA HPTGEKP ANTIGEN; EPITOPE; PROTEIN C 2 H 2 ZFP; TRANSCRIPTION FACTOR CTCF; TRANSCRIPTION FACTOR YY1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ARTICLE; BINDING AFFINITY; CELL CYCLE G2 PHASE; DNA BINDING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MITOSIS; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

EID: 80053459375     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.19.17619     Document Type: Article

References (54)

1. Taylor JH. Nucleic acid synthesis in relation to the cell division cycle. Ann NY Acad Sci 1960; 90:409-21; PMID:13775619; DOI:10.1111/j.1749-6632.1960. tb23259.x.
2. Prescott DM, Bender MA. Synthesis of RNA and protein during mitosis in mammalian tissue culture cells. Exp Cell Res 1962; 26:260-8; PMID:14488623; DOI:10.1016/0014-4827(62)90176-3.
3. Gottesfeld JM, Forbes DJ. Mitotic repression of the transcriptional machinery. Trends Biochem Sci 1997; 22:197-202; PMID:9204705; DOI:10.1016/S0968- 0004(97)01045-1.
4. Martínez-Balbás MA, Dey A, Rabindran SK, Ozato K, Wu C. Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 1995; 83:29-38; PMID:7553870; DOI:10.1016/0092- 8674(95)90231-7.
5. Güttinger S, Laurell E, Kutay U. Orchestrating nuclear envelope disassembly and reassembly during mitosis. Nat Rev Mol Cell Biol 2009; 10:178-91; PMID:19234477; DOI:10.1038/nrm2641.
6. Bellier S, Dubois MF, Nishida E, Almouzni G, Bensaude O. Phosphorylation of the RNA polymerase II largest subunit during Xenopus laevis oocyte maturation. Mol Cell Biol 1997; 17:1434-40; PMID:9032270.
7. Gebara MM, Sayre MH, Corden JL. Phosphorylation of the carboxy-terminal repeat domain in RNA polymerase II by cyclin-dependent kinases is sufficient to inhibit transcription. J Cell Biochem 1997; 64:390- 402; PMID:9057097; DOI:10.1002/(SICI)1097- 4644(19970301)64:3<390::AID-JCB6>3.0.CO;2-Q.
8. Long JJ, Leresche A, Kriwacki RW, Gottesfeld JM. Repression of TFIIH transcriptional activity and TFIIH-associated cdk7 kinase activity at mitosis. Mol Cell Biol 1998; 18:1467-76; PMID:9488463.
9. Lüscher B, Eisenman RN. Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J Cell Biol 1992; 118:775-84; PMID:1500422; DOI:10.1083/jcb.118.4.775.
10. Segil N, Roberts SB, Heintz N. Mitotic phosphorylation of the Oct-1 homeodomain and regulation of Oct-1 DNA binding activity. Science 1991; 254:1814- 6; PMID:1684878; DOI:10.1126/science.1684878.
11. Caelles C, Hennemann H, Karin M. M-phase-specific phosphorylation of the POU transcription factor GHF-1 by a cell cycle-regulated protein kinase inhibits DNA binding. Mol Cell Biol 1995; 15:6694-701; PMID:8524234.
12. Dovat S, Ronni T, Russell D, Ferrini R, Cobb BS, Smale ST. A common mechanism for mitotic inactivation of C2H2 zinc finger DNA-binding domains. Genes Dev 2002; 16:2985-90; PMID:12464629; DOI:10.1101/gad.1040502.
13. Tupler R, Perini G, Green MR. Expressing the human genome. Nature 2001; 409:832-3; PMID:11237001; DOI:10.1038/35057011.
14. Wolfe SA, Nekludova L, Pabo CO. DNA recognition by Cys2His2 zinc finger proteins. Annu Rev Biophys Biomol Struct 2000; 29:183-212; PMID:10940247; DOI:10.1146/annurev.biophys.29.1.183.
15. Laity JH, Lee BM, Wright PE. Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol 2001; 11:39-46; PMID:11179890; DOI:10.1016/S0959-440X(00)00167-6.
16. Wuttke DS, Foster MP, Case DA, Gottesfeld JM, Wright PE. Solution structure of the first three zinc fingers of TFIIIA bound to the cognate DNA sequence: determinants of affinity and sequence specificity. J Mol Biol 1997; 273:183-206; PMID:9367756; DOI:10.1006/jmbi.1997.1291.
17. Choo Y, Klug A. A role in DNA binding for the linker sequences of the first three zinc fingers of TFIIIA. Nucleic Acids Res 1993; 21:3341-6; PMID:8346014; DOI:10.1093/nar/21.15.3341.
18. 2 zincfinger proteins. Evidence for a zinc-finger-specific DNA recognition code. Ann NY Acad Sci 1993; 684:246-9; PMID:8317844; DOI:10.1111/j.1749-6632.1993. tb32299.x.
19. Cui X, Ji D, Fisher DA, Wu Y, Briner DM, Weinstein EJ. Targeted integration in rat and mouse embryos with zinc-finger nucleases. Nat Biotechnol 2011; 29:64-7; PMID:21151125; DOI:10.1038/nbt.1731.
20. Jamieson AC, Miller JC, Pabo CO. Drug discovery with engineered zinc-finger proteins. Nat Rev Drug Discov 2003; 2:361-8; PMID:12750739; DOI:10.1038/nrd1087.
21. Klug A. The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu Rev Biochem 2010; 79:213- 31; PMID:20192761; DOI:10.1146/annurev-biochem- 010909-095056.
22. Santiago Y, Chan E, Liu PQ, Orlando S, Zhang L, Urnov FD, et al. Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci USA 2008; 105:5809-14; PMID:18359850; DOI:10.1073/pnas. 0800940105.
23. Thukral SK, Morrison ML, Young ET. Alanine scanning site-directed mutagenesis of the zinc fingers of transcription factor ADR1: residues that contact DNA and that transactivate. Proc Natl Acad Sci USA 1991; 88:9188-92; PMID:1924382; DOI:10.1073/ pnas.88.20.9188.
24. Clemens KR, Zhang P, Liao X, McBryant SJ, Wright PE, Gottesfeld JM. Relative contributions of the zinc fingers of transcription factor IIIA to the energetics of DNA binding. J Mol Biol 1994; 244:23-35; PMID:7966319; DOI:10.1006/jmbi.1994.1701.
25. Laity JH, Dyson HJ, Wright PE. DNA-induced alphahelix capping in conserved linker sequences is a determinant of binding affinity in Cys(2)-His(2) zinc fingers. J Mol Biol 2000; 295:719-27; PMID:10656784; DOI:10.1006/jmbi. 1999.3406.
26. Jantz D, Berg JM. Reduction in DNA-binding affinity of Cys2His2 zinc finger proteins by linker phosphorylation. Proc Natl Acad Sci USA 2004; 101:7589-93; PMID:15128941; DOI:10.1073/pnas.0402191101.
27. Rizkallah R, Hurt MM. Regulation of the transcription factor YY1 in mitosis through phosphorylation of its DNA-binding domain. Mol Biol Cell 2009; 20:4766-76; PMID:19793915; DOI:10.1091/mbc. E09-04-0264.
28. Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, et al. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 2008; 105:10762-7; PMID:18669648; DOI:10.1073/ pnas.0805139105.
29. Chen RQ, Yang QK, Lu BW, Yi W, Cantin G, Chen YL, et al. CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res 2009; 69:2663-8; PMID:19276368; DOI:10.1158/0008-5472.CAN-08-3222.
30. Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, et al. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2009; 2:46; PMID:19690332; DOI:10.1126/scisignal. 2000007.
31. Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 2010; 3:3; PMID:20068231; DOI:10.1126/scisignal.2000475.
32. Moritz A, Li Y, Guo A, Villen J, Wang Y, MacNeill J, et al. Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci Signal 2010; 3:64; PMID:20736484; DOI:10.1126/ scisignal.2000998.
33. Sullivan M, Morgan DO. Finishing mitosis, one step at a time. Nat Rev Mol Cell Biol 2007; 8:894-903; PMID:17912263; DOI:10.1038/nrm2276.
34. Shi Y, Lee JS, Galvin KM. Everything you have ever wanted to know about Yin Yang 1. Biochim Biophys Acta 1997; 1332:49-66; PMID:9141463.
35. Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function and therapeutic implications in cancer biology. Oncogene 2006; 25:1125-42; PMID:16314846; DOI:10.1038/ sj.onc.1209080.
36. Castellano G, Torrisi E, Ligresti G, Malaponte G, Militello L, Russo AE, et al. The involvement of the transcription factor Yin Yang 1 in cancer development and progression. Cell Cycle 2009; 8:1367-72; PMID:19342874; DOI:10.4161/cc.8.9.8314.
37. Zaravinos A, Spandidos DA. Yin yang 1 expression in human tumors. Cell Cycle 2010; 9:512-22; PMID:20081375; DOI:10.4161/cc.9.3.10588.
38. Bushmeyer S, Park K, Atchison ML. Characterization of functional domains within the multifunctional transcription factor, YY1. J Biol Chem 1995; 270:30213- 20; PMID:8530432; DOI:10.1074/jbc.270.50.30213.
39. Austen M, Luscher B, Luscher-Firzlaff JM. Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55 or cAMP-responsive element-binding protein (CPB)-binding protein. J Biol Chem 1997; 272:1709-17; PMID:8999850; DOI:10.1074/jbc.272.3. 1709.
40. Phillips JE, Corces VG. CTCF: master weaver of the genome. Cell 2009; 137:1194-211; PMID:19563753; DOI:10.1016/j.cell.2009.06.001.
41. Martin D, Pantoja C, Minan AF, Valdes-Quezada C, Molto E, Matesanz F, et al. Genome-wide CTCF distribution in vertebrates defines equivalent sites that aid the identification of disease-associated genes. Nat Struct Mol Biol 2011; 18:708-14; PMID: 21602820.
42. Hans F, Dimitrov S. Histone H3 phosphorylation and cell division. Oncogene 2001; 20:3021-7; PMID:11420717; DOI:10.1038/sj.onc.1204326.
43. Nowak SJ, Corces VG. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet 2004; 20:214-20; PMID:15041176; DOI:10.1016/j. tig.2004.02.007.
44. Johansen KM, Johansen J. Regulation of chromatin structure by histone H3S10 phosphorylation. Chromosome Res 2006; 14:393-404; PMID:16821135; DOI:10.1007/s10577-006-1063-4.
45. Egli D, Birkhoff G, Eggan K. Mediators of reprogramming: transcription factors and transitions through mitosis. Nat Rev Mol Cell Biol 2008; 9:505-16; PMID:18568039; DOI:10.1038/nrm2439.
46. 2 zinc finger domains. Cell Biochem Biophys 2008; 50:111-31; PMID:18253864; DOI:10.1007/s12013-008-9008-5.
47. Jones DR, Prasad AA, Chan PK, Duncker BP. The Dbf4 motif C zinc finger promotes DNA replication and mediates resistance to genotoxic stress. Cell Cycle 2010; 9:2018-26; PMID:20436286; DOI:10.4161/ cc.9.10.11752.
48. Dudekula S, Lee MH, Hsu LJ, Chen SJ, Chang NS. Zfra is a small wizard in the mitochondrial apoptosis. Aging (Albany NY) 2010; 2:1023-9; PMID:21212468.
49. He S, Davie JR. Sp1 and Sp3 foci distribution throughout mitosis. J Cell Sci 2006; 119:1063-70; PMID:16492704; DOI:10.1242/jcs.02829.
50. Whitfield ML, George LK, Grant GD, Perou CM. Common markers of proliferation. Nat Rev Cancer 2006; 6:99-106; PMID:16491069; DOI:10.1038/ nrc1802.
51. Baak JP, Gudlaugsson E, Skaland I, Guo LH, Klos J, Lende TH, et al. Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers. Breast Cancer Res Treat 2009; 115:241-54; PMID:18665447; DOI:10.1007/ s10549-008-0126-y.
52. Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, et al. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Am J Surg Pathol 2006; 30:657-64; PMID:16699322; DOI:10.1097/01. pas.0000202048.28203.25.
53. Kim YJ, Ketter R, Steudel WI, Feiden W. Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas. Am J Clin Pathol 2007; 128:118-25; PMID:17580279; DOI:10.1309/HXUNAG34B3CEFDU8.
54. van Diest PJ, van der Wall E, Baak JP. Prognostic value of proliferation in invasive breast cancer: a review. J Clin Pathol 2004; 57:675-81; PMID:15220356; DOI:10.1136/jcp.2003.010777.